COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 2802: Articles 28011-28020  | Next

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
Laha, S., Chakraborty, J., Das, S., Biswas, S., Manna, S. K., Chatterjee, R.
10.1101/2020.05.03.066266 — Posted: 2020-05-04 Discussion: Onsite
Temporal signal and the phylodynamic threshold of SARS-CoV-2
Duchene, S., Featherstone, L., Haritopoulou-Sinanidou, M., Rambaut, A., Lemey, P., Baele, G.
10.1101/2020.05.04.077735 — Posted: 2020-05-04
Complexity in SARS-CoV-2 genome data: Price theory of mutant isolates
Mandal, S., Singh, R. K. S., Sharma, S. K., Malik, M. Z., Singh, R. K. B.
10.1101/2020.05.04.077511 — Posted: 2020-05-04
Pathogen Reduction Of SARS-CoV-2 Virus In Plasma And Whole Blood Using Riboflavin And UV Light
Ragan, I., Hartson, L., Pidcoke, H., Bowen, R., Goodrich, R. P.
10.1101/2020.05.03.074971 — Posted: 2020-05-04
The UCSC SARS-CoV-2 Genome Browser
Fernandes, J. D., Hinrichs, A. S., Clawson, H., Navarro Gonzales, J., Lee, B. T., Nassar, L. R., Raney, B. J., Rosenbloom, K. R., Nerli, S., Rao, A. A., Schmelter, D., Zweig, A. S., Lowe, T. M., Ares, M., Corbett-Detig, R., Kent, W. J., Haussler, D., Haeussler, M.
10.1101/2020.05.04.075945 — Posted: 2020-05-04
Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19
MacGowan, S. A., Barton, G. J.
10.1101/2020.05.03.074781 — Posted: 2020-05-04
Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease
Günther, S., Reinke, P. Y., Oberthuer, D., Yefanov, O., Ginn, H., Meier, S., Lane, T. J., Lorenzen, K., Gelisio, L., Brehm, W., Dunkel, I., Domaracky, M., Saouane, S., Lieske, J., Ehrt, C., Koua, F., Tolstikova, A., White, T. A., Groessler, M., Fleckenstein, H., Trost, F., Galchenkova, M., Gevorkov, Y., Li, C., Awel, S., Peck, A., Xavier, P. L., Barthelmess, M., Schlünzen, F., Werner, N., Andaleeb, H., Ullah, N., Falke, S., Franca, B. A., Schwinzer, M., Brognaro, H., Seychell, B., Gieseler, H., Melo, D., Zaitsev-Doyle, J. J., Norton-Baker, B., Knoska, J., Esperanza, G., Mashhour, A. R., Guicking, F., Hennicke, V., Fischer, P., Rogers, C., Monteiro, D. C., Hakanpää, J., Meyer, J., Noei, H., Gribbon, P., Ellinger, B., Kuzikov, M., Wolf, M., Zhang, L., Sun, X., Pletzer-Zelgert, J., Wollenhaupt, J., Feiler, C., Weiss, M., Schulz, E., Mehrabi, P., Schmidt, C., Schubert, R., Han, H., Krichel, B., Fernández-García, Y., Escudero-Pérez, B., Günther, S., Turk, D., Uetrecht, C., Beck, T., Tidow, H., Chari, A., Zaliani, A., Rarey, M., Cox, R., Hilgenfeld, R., Chapman, H. N., Pearson, A. R., Betzel, C., Meents, A.
10.1101/2020.05.02.043554 — Posted: 2020-05-04
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Vuong, W., Khan, M. B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H. A., McKay, R. T., van Belkum, M. J., Joyce, M., Young, H. S., Tyrrell, D. L., Vederas, J. C., Lemieux, M. J.
10.1101/2020.05.03.073080 — Posted: 2020-05-04 Discussion: Onsite
Structure of anxiety associated with the COVID-19 pandemic in the Russian-speaking sample: results from on-line survey
Sorokin, M. Y., Kasyanov, E. D., Rukavishnikov, G. V., Makarevich, O. V., Neznanov, N. G., Lutova, N. B., Mazo, G. E.
10.1101/2020.04.28.20074302 — Posted: 2020-05-04
Development and validation of direct RT-LAMP for SARS-CoV-2
Mohon, A. N., Hundt, J., van Marle, G., Pabbaraju, K., Berenger, B., Griener, T., Lisboa, L., Church, D., Czub, M., Greninger, A., Jerome, K., Doolan, C., Pillai, D. R.
10.1101/2020.04.29.20075747 — Posted: 2020-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).